Encochleated oral amphotericin

amphotericin · Matinas BioPharma Nanotechnologies, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Encochleated oral amphotericin, covering 2022-09-15 to 2023-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT) [Phase 1, Phase 2]